{"id":55855,"date":"2023-04-14T23:07:21","date_gmt":"2023-04-14T21:07:21","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\/"},"modified":"2023-04-14T23:07:21","modified_gmt":"2023-04-14T21:07:21","slug":"greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\/","title":{"rendered":"Greenbrook TMS Announces Dates for Its Fourth Quarter and Year End 2022 Financial Results"},"content":{"rendered":"
\n

TORONTO–(BUSINESS WIRE)–Greenbrook TMS Inc. (NASDAQ: GBNH) (\u201cGreenbrook<\/b>\u201d or the \u201cCompany<\/b>\u201d), will release its 2022 fourth quarter and year end operational and financial results after market hours on April 17, 2023.<\/p>\n

\nFOURTH QUARTER AND YEAR END 2022 CONFERENCE CALL DETAILS:<\/b><\/p>\n

\nBill Leonard, President and Chief Executive Officer, and Erns Loubser, Chief Financial Officer, will host a conference call at 10:00 a.m. (Eastern Time) on April 18, 2023 to discuss the financial results for the quarter.<\/p>\n

\nDial in Numbers:<\/b><\/p>\n

\nToll Free North America: 1 (888) 396-8049
\n
Toronto: (416) 764-8646<\/p>\n

\nWebcast:<\/b><\/p>\n

\nFor more information or to listen to the call via webcast, please visit:
\n
www.greenbrooktms.com\/investors\/events.htm<\/a><\/p>\n

\nFor those that plan on accessing the conference call or webcast, please allow ample time prior to the call time.<\/p>\n

\nConference Call Replay:<\/b><\/p>\n

\nFollowing the live call, a replay will be available on the Investor Relations section of the Company\u2019s website, www.greenbrooktms.com\/investors\/events.htm<\/a><\/p>\n

\nAbout Greenbrook TMS Inc.<\/b><\/p>\n

\nOperating through 133 Company-operated treatment centers (following completion of the Company’s previously-announced restructuring plan), Greenbrook is a leading provider of Transcranial Magnetic Stimulation (“TMS<\/b>“) and Spravato\u00ae (esketamine nasal spray), FDA-cleared, non-invasive therapies for the treatment of Major Depressive Disorder (“MDD<\/b>“) and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Spravato\u00ae is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. Greenbrook has provided more than one million treatments to over 27,000 patients struggling with depression.<\/p>\n

Contacts<\/b> <\/p>\n

\nFor further information please contact:<\/b>
Glen Akselrod
\n
Investor Relations
\n
Greenbrook TMS Inc.<\/p>\n

\nContact Information:
\n
investorrelations@greenbrooktms.com<\/a>
1-855-797-4867<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

TORONTO–(BUSINESS WIRE)–Greenbrook TMS Inc. (NASDAQ: GBNH) (\u201cGreenbrook\u201d or the \u201cCompany\u201d), will release its 2022 fourth quarter and year end operational and financial results after market hours on April 17, 2023. FOURTH QUARTER AND YEAR END 2022 CONFERENCE CALL DETAILS: Bill Leonard, President and Chief Executive Officer, and Erns Loubser, Chief Financial Officer, will host a … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55855","6":"format-standard","7":"category-industry"},"yoast_head":"\nGreenbrook TMS Announces Dates for Its Fourth Quarter and Year End 2022 Financial Results - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Greenbrook TMS Announces Dates for Its Fourth Quarter and Year End 2022 Financial Results - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"TORONTO–(BUSINESS WIRE)–Greenbrook TMS Inc. (NASDAQ: GBNH) (\u201cGreenbrook\u201d or the \u201cCompany\u201d), will release its 2022 fourth quarter and year end operational and financial results after market hours on April 17, 2023. FOURTH QUARTER AND YEAR END 2022 CONFERENCE CALL DETAILS: Bill Leonard, President and Chief Executive Officer, and Erns Loubser, Chief Financial Officer, will host a ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-14T21:07:21+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Greenbrook TMS Announces Dates for Its Fourth Quarter and Year End 2022 Financial Results\",\"datePublished\":\"2023-04-14T21:07:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\\\/\"},\"wordCount\":288,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\\\/\",\"name\":\"Greenbrook TMS Announces Dates for Its Fourth Quarter and Year End 2022 Financial Results - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2023-04-14T21:07:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Greenbrook TMS Announces Dates for Its Fourth Quarter and Year End 2022 Financial Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Greenbrook TMS Announces Dates for Its Fourth Quarter and Year End 2022 Financial Results - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\/","og_locale":"en_US","og_type":"article","og_title":"Greenbrook TMS Announces Dates for Its Fourth Quarter and Year End 2022 Financial Results - Pharma Trend","og_description":"TORONTO–(BUSINESS WIRE)–Greenbrook TMS Inc. (NASDAQ: GBNH) (\u201cGreenbrook\u201d or the \u201cCompany\u201d), will release its 2022 fourth quarter and year end operational and financial results after market hours on April 17, 2023. FOURTH QUARTER AND YEAR END 2022 CONFERENCE CALL DETAILS: Bill Leonard, President and Chief Executive Officer, and Erns Loubser, Chief Financial Officer, will host a ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-14T21:07:21+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Greenbrook TMS Announces Dates for Its Fourth Quarter and Year End 2022 Financial Results","datePublished":"2023-04-14T21:07:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\/"},"wordCount":288,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\/","url":"https:\/\/pharma-trend.com\/en\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\/","name":"Greenbrook TMS Announces Dates for Its Fourth Quarter and Year End 2022 Financial Results - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2023-04-14T21:07:21+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/greenbrook-tms-announces-dates-for-its-fourth-quarter-and-year-end-2022-financial-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Greenbrook TMS Announces Dates for Its Fourth Quarter and Year End 2022 Financial Results"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55855"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55855\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55855"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55855"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}